 | SBL | Name: | L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ALANINE | Formula: | C17 H22 B N2 O6 | SMILES: | O=C(O)C(N)CO[B-](O)(O)C(NC(=O)C)Cc2cccc1ccccc12 | InChi: | InChI=1S/C17H22BN2O6/c1-11(21)20-16(18(24,25)26-10-15(19)17(22)23)9-13-7-4-6-12-5-2-3-8-14(12)13/h2-8,15-16,24-25H,9-10,19H2,1H3,(H,20,21)(H,22,23)/q-1/t15-,16-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-(acetylamino)-2-naphthalen-1-ylethyl](dihydroxy)(L-serinato-kappaO~3~)borate(1-) |
|
 | V4N | Name: | (5-methanoyl-2-nitro-phenyl) 3-chloranylbenzoate | Formula: | C14 H8 Cl N O5 | SMILES: | [O-][N+](=O)c1ccc(C=O)cc1OC(=O)c2cccc(Cl)c2 | InChi: | InChI=1S/C14H8ClNO5/c15-11-3-1-2-10(7-11)14(18)21-13-6-9(8-17)4-5-12(13)16(19)20/h1-8H | Definition date: | 2021-04-12 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | (5-methanoyl-2-nitro-phenyl) 3-chloranylbenzoate |
|
 | TYC | Name: | L-TYROSINAMIDE | Formula: | C9 H12 N2 O2 | SMILES: | O=C(N)C(N)Cc1ccc(O)cc1 | InChi: | InChI=1S/C9H12N2O2/c10-8(9(11)13)5-6-1-3-7(12)4-2-6/h1-4,8,12H,5,10H2,(H2,11,13)/t8-/m0/s1 | Definition date: | 2004-12-06 | Last modified: | 2024-09-27 | Identifier: | L-tyrosinamide |
|
 | ZDL | Name: | 1,3-dimethylimidazolidine | Formula: | C5 H12 N2 | SMILES: | CN1CCN(C)C1 | InChi: | InChI=1S/C5H12N2/c1-6-3-4-7(2)5-6/h3-5H2,1-2H3 | Definition date: | 2023-06-23 | Last modified: | 2024-09-27 | Release date: | 2023-07-12 | Identifier: | 1,3-dimethylimidazolidine |
|
 | T4Z | Name: | 2-(4-chlorophenyl)sulfanyl-~{N}-(3-sulfanylpropyl)ethanamide | Formula: | C11 H14 Cl N O S2 | SMILES: | SCCCNC(=O)CSc1ccc(Cl)cc1 | InChi: | InChI=1S/C11H14ClNOS2/c12-9-2-4-10(5-3-9)16-8-11(14)13-6-1-7-15/h2-5,15H,1,6-8H2,(H,13,14) | Definition date: | 2020-12-15 | Last modified: | 2024-09-27 | Release date: | 2021-07-07 | Identifier: | 2-(4-chlorophenyl)sulfanyl-~{N}-(3-sulfanylpropyl)ethanamide |
|
 | QQM | Name: | N-[3-({4-[4-(4-fluorophenyl)-2-(3-hydroxypropyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)-4-methoxyphenyl]propanamide | Formula: | C27 H28 F N5 O3 | SMILES: | c4c(ccc(c1nc(CCCO)nc1c2cc(ncc2)Nc3c(ccc(NC(CC)=O)c3)OC)c4)F | InChi: | InChI=1S/C27H28FN5O3/c1-3-25(35)30-20-10-11-22(36-2)21(16-20)31-24-15-18(12-13-29-24)27-26(17-6-8-19(28)9-7-17)32-23(33-27)5-4-14-34/h6-13,15-16,34H,3-5,14H2,1-2H3,(H,29,31)(H,30,35)(H,32,33) | Definition date: | 2019-12-09 | Last modified: | 2024-09-27 | Release date: | 2020-04-22 | Identifier: | N-[3-({4-[4-(4-fluorophenyl)-2-(3-hydroxypropyl)-1H-imidazol-5-yl]pyridin-2-yl}amino)-4-methoxyphenyl]propanamide |
|
 | WTE | Name: | N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-[(2S,3Z)-1-[(2S)-oxolan-2-yl]-3-(2-oxooxolan-3-ylidene)propan-2-yl]-L-leucinamide | Formula: | C34 H42 F N3 O7 | SMILES: | Fc1ccc(cc1)CC(NC(=O)OCc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CC1CCCO1)C=C1CCOC1=O | InChi: | InChI=1S/C34H42FN3O7/c1-22(2)17-29(31(39)36-27(20-28-9-6-15-43-28)19-25-14-16-44-33(25)41)37-32(40)30(18-23-10-12-26(35)13-11-23)38-34(42)45-21-24-7-4-3-5-8-24/h3-5,7-8,10-13,19,22,27-30H,6,9,14-18,20-21H2,1-2H3,(H,36,39)(H,37,40)(H,38,42)/b25-19-/t27-,28+,29+,30+/m1/s1 | Synonyms: | GSK4365096A | Definition date: | 2023-10-12 | Last modified: | 2024-09-27 | Release date: | 2024-03-13 | Identifier: | N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-[(2S,3Z)-1-[(2S)-oxolan-2-yl]-3-(2-oxooxolan-3-ylidene)propan-2-yl]-L-leucinamide |
|
 | TYE | Name: | 4-[(2S)-2-amino-3-hydroxypropyl]phenol | Formula: | C9 H13 N O2 | SMILES: | Oc1ccc(cc1)CC(N)CO | InChi: | InChI=1S/C9H13NO2/c10-8(6-11)5-7-1-3-9(12)4-2-7/h1-4,8,11-12H,5-6,10H2/t8-/m0/s1 | Synonyms: | tyrosinol | Definition date: | 2010-10-11 | Last modified: | 2024-09-27 | Identifier: | 4-[(2S)-2-amino-3-hydroxypropyl]phenol |
|
 | ZV4 | Name: | (2S)-2-azanyl-3-(4-phosphonophenyl)propanoic acid | Formula: | C9 H12 N O5 P | SMILES: | N[CH](Cc1ccc(cc1)[P](O)(O)=O)C(O)=O | InChi: | InChI=1S/C9H12NO5P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1 | Synonyms: | phosphophenylalanine | Definition date: | 2023-04-06 | Last modified: | 2024-09-27 | Release date: | 2023-04-19 | Identifier: | (2~{S})-2-azanyl-3-(4-phosphonophenyl)propanoic acid |
|
 | SQW | Name: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate | Formula: | C15 H17 N O3 | SMILES: | CC(C)OC(=O)CCC(=O)n1ccc2ccccc12 | InChi: | InChI=1S/C15H17NO3/c1-11(2)19-15(18)8-7-14(17)16-10-9-12-5-3-4-6-13(12)16/h3-6,9-11H,7-8H2,1-2H3 | Definition date: | 2020-11-30 | Last modified: | 2024-09-27 | Release date: | 2021-08-04 | Identifier: | propan-2-yl 4-indol-1-yl-4-oxidanylidene-butanoate |
|
 | T51 | Name: | N-[2-({2-[({4-[(4-methylpiperazin-1-yl)methyl]benzoyl}amino)methyl]benzyl}oxy)phenyl]-3-nitrobenzamide | Formula: | C34 H35 N5 O5 | SMILES: | O=[N+](c1cc(ccc1)C(=O)Nc2c(cccc2)OCc3ccccc3CNC(=O)c4ccc(cc4)CN5CCN(CC5)C)[O-] | InChi: | InChI=1S/C34H35N5O5/c1-37-17-19-38(20-18-37)23-25-13-15-26(16-14-25)33(40)35-22-28-7-2-3-8-29(28)24-44-32-12-5-4-11-31(32)36-34(41)27-9-6-10-30(21-27)39(42)43/h2-16,21H,17-20,22-24H2,1H3,(H,35,40)(H,36,41) | Definition date: | 2015-09-30 | Last modified: | 2024-09-27 | Release date: | 2016-09-21 | Identifier: | N-[2-({2-[({4-[(4-methylpiperazin-1-yl)methyl]benzoyl}amino)methyl]benzyl}oxy)phenyl]-3-nitrobenzamide |
|
 | RX9 | Name: | Dehydroisoleucine | Formula: | C6 H11 N O2 | SMILES: | CCC(C)=C(N)C(O)=O | InChi: | InChI=1S/C6H11NO2/c1-3-4(2)5(7)6(8)9/h3,7H2,1-2H3,(H,8,9)/b5-4+ | Synonyms: | (E)-2-azanyl-3-methyl-pent-2-enoic acid | Definition date: | 2022-12-09 | Last modified: | 2024-09-27 | Release date: | 2023-01-18 | Identifier: | (~{E})-2-azanyl-3-methyl-pent-2-enoic acid |
|
 | IYR | Name: | 3-IODO-TYROSINE | Formula: | C9 H10 I N O3 | SMILES: | Ic1cc(ccc1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-iodo-L-tyrosine |
|
 | WE0 | Name: | (3~{S})-3-[[(3~{S})-2-[(2~{S})-3-methyl-2-(naphthalen-2-ylcarbonylamino)butanoyl]-4-oxidanyl-2-azabicyclo[2.2.2]octan-3-yl]carbonylamino]-4-oxidanyl-butanoic acid | Formula: | C28 H35 N3 O7 | SMILES: | CC(C)[CH](NC(=O)c1ccc2ccccc2c1)C(=O)N3C4CCC(O)(CC4)[CH]3C(=O)N[CH](CO)CC(O)=O | InChi: | InChI=1S/C28H35N3O7/c1-16(2)23(30-25(35)19-8-7-17-5-3-4-6-18(17)13-19)27(37)31-21-9-11-28(38,12-10-21)24(31)26(36)29-20(15-32)14-22(33)34/h3-8,13,16,20-21,23-24,32,38H,9-12,14-15H2,1-2H3,(H,29,36)(H,30,35)(H,33,34)/t20-,21-,23-,24+,28-/m0/s1 | Definition date: | 2016-12-12 | Last modified: | 2024-09-27 | Release date: | 2017-12-20 | Identifier: | (3~{S})-3-[[(3~{S})-2-[(2~{S})-3-methyl-2-(naphthalen-2-ylcarbonylamino)butanoyl]-4-oxidanyl-2-azabicyclo[2.2.2]octan-3-yl]carbonylamino]-4-oxidanyl-butanoic acid |
|
 | HPH | Name: | (2S)-2-amino-3-phenylpropane-1,1-diol | Formula: | C9 H13 N O2 | SMILES: | OC(O)C(N)Cc1ccccc1 | InChi: | InChI=1S/C9H13NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8-9,11-12H,6,10H2/t8-/m0/s1 | Synonyms: | (2S)-2-amino-3-phenylpropane-1,1-diol | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-phenylpropane-1,1-diol |
|
 | QC4 | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-5-oxo-4-[(2,3,5-trifluoro-4-hydroxyphenyl)methylidene]-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H14 F3 N3 O5 | SMILES: | NC(C(O)C)C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(F)c(c(c2F)F)O | InChi: | InChI=1S/C15H14F3N3O5/c1-5(22)12(19)14-20-8(15(26)21(14)4-9(23)24)3-6-2-7(16)13(25)11(18)10(6)17/h2-3,5,12,22,25H,4,19H2,1H3,(H,23,24)/b8-3-/t5-,12+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2019-10-11 | Last modified: | 2024-09-27 | Release date: | 2020-10-14 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-5-oxo-4-[(2,3,5-trifluoro-4-hydroxyphenyl)methylidene]-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | TYF | Name: | (2S)-2-hydroxy-3-(4-hydroxyphenyl)propanoic acid | Formula: | C9 H10 O4 | SMILES: | O=C(O)C(O)Cc1ccc(O)cc1 | InChi: | InChI=1S/C9H10O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8,10-11H,5H2,(H,12,13)/t8-/m0/s1 | Definition date: | 2013-10-01 | Last modified: | 2024-09-27 | Release date: | 2013-10-30 | Identifier: | (2S)-2-hydroxy-3-(4-hydroxyphenyl)propanoic acid |
|
 | V4T | Name: | 1-[(4R,7S)-12-chloro-14-fluoro-13-(2-fluoro-6-hydroxyphenyl)-4-methyl-10-oxa-2,5,16,18-tetrazatetracyclo[9.7.1.0^(2,7).0^(15,19)]nonadeca-1(18),11,13,15(19),16-pentaen-5-en-1-one-yl]prop-2 | Formula: | C24 H21 Cl F2 N4 O3 | SMILES: | C[CH]1CN2[CH](CCOc3c(Cl)c(c(F)c4ncnc2c34)c5c(O)cccc5F)CN1C(=O)C=C | InChi: | InChI=1S/C24H21ClF2N4O3/c1-3-16(33)30-10-13-7-8-34-23-19-22(28-11-29-24(19)31(13)9-12(30)2)21(27)18(20(23)25)17-14(26)5-4-6-15(17)32/h3-6,11-13,32H,1,7-10H2,2H3/t12-,13+/m1/s1 | Synonyms: | 146250992 | Definition date: | 2021-04-12 | Last modified: | 2024-09-27 | Release date: | 2022-04-20 |
|
 | ZV7 | Name: | 2-chloro-N-(3-oxopropyl)acetohydrazide | Formula: | C5 H9 Cl N2 O2 | SMILES: | ClCC(=O)N(N)CCC=O | InChi: | InChI=1S/C5H9ClN2O2/c6-4-5(10)8(7)2-1-3-9/h3H,1-2,4,7H2 | Definition date: | 2023-04-06 | Last modified: | 2024-09-27 | Release date: | 2024-04-03 | Identifier: | 2-chloro-N-(3-oxopropyl)acetohydrazide |
|
 | SBP | Name: | [3-(1,3,2-DIOXABOROLAN-2-YLOXY)PROPYL]GUANIDINE | Formula: | C6 H15 B N3 O3 | SMILES: | O(B1OCCO1)CCCNC(=[NH2+])N | InChi: | InChI=1S/C6H14BN3O3/c8-6(9)10-2-1-3-11-7-12-4-5-13-7/h1-5H2,(H4,8,9,10)/p+1 | Definition date: | 2004-01-26 | Last modified: | 2024-09-27 | Identifier: | amino{[3-(1,3,2-dioxaborolan-2-yloxy)propyl]amino}methaniminium |
|
 | ZDP | Name: | (2S,6S)-2,6-DIAMINO-2-METHYLHEPTANEDIOIC ACID | Formula: | C8 H16 N2 O4 | SMILES: | O=C(O)C(N)(CCCC(N)C(=O)O)C | InChi: | InChI=1S/C8H16N2O4/c1-8(10,7(13)14)4-2-3-5(9)6(11)12/h5H,2-4,9-10H2,1H3,(H,11,12)(H,13,14)/t5-,8-/m0/s1 | Definition date: | 2006-04-13 | Last modified: | 2024-09-27 | Identifier: | (2S,6S)-2,6-diamino-2-methylheptanedioic acid |
|
 | TYI | Name: | 3,5-DIIODOTYROSINE | Formula: | C9 H9 I2 N O3 | SMILES: | Ic1cc(cc(I)c1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3,5-diiodo-L-tyrosine |
|
 | T53 | Name: | N-[2-({3-[({4-[(4-methylpiperazin-1-yl)methyl]benzoyl}amino)methyl]benzyl}oxy)phenyl]-3-nitrobenzamide | Formula: | C34 H35 N5 O5 | SMILES: | O=[N+]([O-])c1cccc(c1)C(=O)Nc2ccccc2OCc3cc(ccc3)CNC(=O)c4ccc(cc4)CN5CCN(CC5)C | InChi: | InChI=1S/C34H35N5O5/c1-37-16-18-38(19-17-37)23-25-12-14-28(15-13-25)33(40)35-22-26-6-4-7-27(20-26)24-44-32-11-3-2-10-31(32)36-34(41)29-8-5-9-30(21-29)39(42)43/h2-15,20-21H,16-19,22-24H2,1H3,(H,35,40)(H,36,41) | Definition date: | 2015-09-30 | Last modified: | 2024-09-27 | Release date: | 2016-09-21 | Identifier: | N-[2-({3-[({4-[(4-methylpiperazin-1-yl)methyl]benzoyl}amino)methyl]benzyl}oxy)phenyl]-3-nitrobenzamide |
|
 | ZDR | Name: | (2R,6S)-2,6-DIAMINO-2-METHYLHEPTANEDIOIC ACID | Formula: | C8 H16 N2 O4 | SMILES: | O=C(O)C(N)(CCCC(N)C(=O)O)C | InChi: | InChI=1S/C8H16N2O4/c1-8(10,7(13)14)4-2-3-5(9)6(11)12/h5H,2-4,9-10H2,1H3,(H,11,12)(H,13,14)/t5-,8+/m0/s1 | Definition date: | 2006-04-13 | Last modified: | 2024-09-27 | Identifier: | (2R,6S)-2,6-diamino-2-methylheptanedioic acid |
|
 | TYJ | Name: | 2,5-dihydroxy-N-methyl-L-tyrosine | Formula: | C10 H13 N O5 | SMILES: | O=C(O)C(NC)Cc1c(O)cc(O)c(O)c1 | InChi: | InChI=1S/C10H13NO5/c1-11-6(10(15)16)2-5-3-8(13)9(14)4-7(5)12/h3-4,6,11-14H,2H2,1H3,(H,15,16)/t6-/m0/s1 | Definition date: | 2011-02-09 | Last modified: | 2024-09-27 | Identifier: | 2,5-dihydroxy-N-methyl-L-tyrosine |
|